John D. Salamone

Active 1982–2025

Also published as
John, D. Salamone
126
Papers
20,023
Citations
86
h-index
125
i10-index

Citations

Citations per year for John D. Salamone1982: 10 citations1983: 1 citations1984: 3 citations1985: 8 citations1986: 6 citations1987: 9 citations1988: 11 citations1989: 11 citations1990: 14 citations1991: 28 citations1992: 33 citations1993: 56 citations1994: 116 citations1995: 40 citations1996: 114 citations1997: 79 citations1998: 123 citations1999: 141 citations2000: 90 citations2001: 114 citations2002: 170 citations2003: 145 citations2004: 164 citations2005: 202 citations2006: 246 citations2007: 229 citations2008: 248 citations2009: 280 citations2010: 294 citations2011: 191 citations2012: 300 citations2013: 294 citations2014: 303 citations2015: 308 citations2016: 406 citations2017: 116 citations2018: 280 citations2019: 370 citations2020: 511 citations2021: 350 citations2022: 452 citations2023: 281 citations2024: 321 citations2025: 138 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,846 citing papers, 38.6% of this breakdownUnited Kingdom: 441 citing papers, 9.2% of this breakdownCanada: 287 citing papers, 6% of this breakdownGermany: 229 citing papers, 4.8% of this breakdownItaly: 218 citing papers, 4.5% of this breakdownNetherlands: 180 citing papers, 3.8% of this breakdownFrance: 165 citing papers, 3.4% of this breakdownChina: 157 citing papers, 3.3% of this breakdownSpain: 156 citing papers, 3.3% of this breakdownAustralia: 114 citing papers, 2.4% of this breakdownSweden: 93 citing papers, 1.9% of this breakdownSwitzerland: 89 citing papers, 1.9% of this breakdown
0%38.6%Other 16.9%

Fields

  • Neuroscience56.5%
  • Medicine24.8%
  • Psychology9.7%
  • Biochemistry, Genetics and Molecular Biology5.8%
  • Nursing0.7%
  • Agricultural and Biological Sciences0.4%
  • Other2.1%

Topics

  • Neurotransmitter Receptor Influence on Behavior13.5%
  • Neuroscience and Neuropharmacology Research6.2%
  • Neural and Behavioral Psychology Studies5.2%
  • Receptor Mechanisms and Signaling4.5%
  • Memory and Neural Mechanisms4.5%
  • Neuroendocrine regulation and behavior3.3%
  • Other62.8%

Coauthors

All papers

Open in search
  1. The Mysterious Motivational Functions of Mesolimbic Dopamine

    Authors: , - Neuron 2012 cited by 1,407

  2. Neurobiology of Exercise

    Authors: , , , , , , , , , , , , , , , , , , - Obesity 2006 cited by 941

  3. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits

    Authors: , , , - Psychopharmacology 2007 cited by 1,000

  4. The Neurobiology of Activational Aspects of Motivation: Exertion of Effort, Effort-Based Decision Making, and the Role of Dopamine

    Authors: , - Annual Review of Psychology 2023 cited by 86

  5. Brain mechanisms underlying apathy

    Authors: , , , - Journal of Neurology Neurosurgery & Psychiatry 2018 cited by 189

  6. Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology

    Authors: , , , , - Brain 2016 cited by 355

  7. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization

    Authors: , , , , , , , , - Psychopharmacology 2016 cited by 96

  8. Mesolimbic Dopamine and the Regulation of Motivated Behavior

    Authors: , , , , , - Current topics in behavioral neurosciences 2015 cited by 199

  9. Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task: Pharmacological Studies and the Role of Individual Differences

    Authors: , , , , , , , , , - PLoS ONE 2012 cited by 196

  10. Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression

    Authors: , , - Frontiers in Pharmacology 2018 cited by 112

  11. Beyond the symptom: the biology of fatigue

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Asya Rolls, John D. Salamone, Clifford B. Saper, Vicky Whittemore, Glenn R. Wylie, Jarred Younger, Phyllis C. Zee, H. Craig Heller - SLEEP 2023 cited by 45

  12. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine

    Authors: , - Behavioural Brain Research 2002 cited by 802

  13. Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure

    Authors: , , - Behavioural Brain Research 1994 cited by 469

  14. Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure

    Authors: , , , , , - Psychopharmacology 1991 cited by 438

  15. The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation

    Authors: , , , , , - Pharmacological Reviews 2018 cited by 100

  16. Vigor, Effort-Related Aspects of Motivation and Anhedonia

    Authors: , - Current topics in behavioral neurosciences 2022 cited by 46

  17. Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: Suppression of high effort activity by the serotonin transport inhibitor fluoxetine

    Authors: , , , , , , , , , , , - Pharmacology Biochemistry and Behavior 2021 cited by 29

  18. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior

    Authors: , , , , , , - Neuropsychopharmacology 2015 cited by 81

  19. Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles

    Authors: , , , , - Psychopharmacology 2023 cited by 18

  20. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine

    Authors: , , , - Current Opinion in Pharmacology 2004 cited by 457

  21. The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

    Authors: , , , , , , , , , , , - Neuropsychopharmacology 2007 cited by 160

  22. Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research

    Authors: , , , , - Frontiers in Behavioral Neuroscience 2018 cited by 140

  23. The VMAT-2 Inhibitor Tetrabenazine Affects Effort-Related Decision Making in a Progressive Ratio/Chow Feeding Choice Task: Reversal with Antidepressant Drugs

    Authors: , , , , , , , , , , , , , - PLoS ONE 2014 cited by 109

  24. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion

    Authors: , , , , , , , - Psychopharmacology 2014 cited by 96